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a primary manifestation of gastric carcinoma
in a young adult: a case report and review of
the literature
Kim Moubax1, Wim Wuyts2, Vincent Vandecaveye3 and Hans Prenen1*Abstract
Background: Lymphangitic carcinomatosis as a manifestation of gastric carcinoma is rare. The presenting
symptoms are misleading and nonspecific, often resulting in delayed diagnosis.
Case presentation: We present a case of a 24 year old male with progressive dyspnea. Initial radiologic assessment
suggested interstitial lung disease, which was subsequently treated with antibiotics and corticosteroids. However,
endoscopy and whole body diffusion-weighted magnetic resonance imaging revealed a metastatic gastric cancer
with the presence of lymphangitic carcinomatosis.
Conclusions: Pulmonary lymphangitic carcinomatosis is a rare manifestation of metastatic gastric cancer. Patients
present with severe but non-specific respiratory complaints. Definitive diagnosis can be achieved by transbronchial
biopsy. Prognosis is poor and optimal treatment is not defined. Whole body diffusion-weighted magnetic
resonance imaging is a promising imaging tool for the diagnosis of metastatic gastric cancer.
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Pulmonary lymphangitic carcinomatosis is present in
6-8% of patients with lung metastases [1]. Infiltration of
the pleural, peribronchial and perivascular lymphatics
by neoplastic cells was first noted in 1829. The histo-
pathology was described in detail in 1874. The spread of
tumour cells to the pulmonary lymphatic system or the
adjacent interstitial tissue results in thickening of the
bronchovascular bundles and septa. Desmoplastic reac-
tion, due to proliferation of neoplastic cells and lymph-
atic dilatation by edema fluid or tumour secretions
contribute to this interstitial thickening [2]. Spread of
the neoplasm outside the interstitium and lymphatic
spaces into the adjacent parenchyma can result in a
nodular pattern [2].* Correspondence: hans.prenen@uzleuven.be
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reproduction in any medium, provided the orHerein we report a very rare case of lymphangitic car-
cinomatosis as a primary manifestation of gastric carcin-
oma in a young adult.Case Presentation
A 24 year old man presented at the emergency depart-
ment after an episode of hemoptysis. For six months he
complained about a dry cough. There was no respiratory-
related pain but he had experienced shortness of breath
during exercise for four weeks. He had not suffered from
any fever or chills in the last six months. He reported oc-
casional night sweats in the past three months.
At the age of six he had suffered from tuberculosis but
had made a complete recovery. He didn’t smoke or use
drugs or medication routinely. His family history was
negative. The patient had no pets and had never been
exposed to products that cause pulmonary damage.
On physical examination the lungs were clear on aus-
cultation and he had normal heart sounds. His blood
pressure was 130/80, his heart rate was 83 beats perl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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frequency was fourteen times per minute.
There was a slight decrease in arterial pO2 (90 mmHg)
with a normal pCO2 (38 mmHg).
Chest radiography showed a diffuse reticulonodular
pattern (Figure 1). An additional computed tomography
(CT) showed areas of ground-opacification and diffusely
thickened interlobular septa. There were also hilar and
mediastinal lymphadenopathies (Figure 2A).
Radiological evaluation was most suggestive of intersti-
tial lung disease with a broad differential diagnosis includ-
ing: infections other than tuberculosis, hypersensitivity
pneumonitis, vasculitis, sarcoidosis, non-specific intersti-
tial pneumonia, pulmonary alveolar proteinosis and lym-
phangitic carcinomatosis.
Biochemically there were no signs of inflammation
(Table 1). An auto-immune disease was suspected so auto-
antibodies were determined. Antinuclear Factor, Anti-
Neutrophil Cytoplasmic Antibody, anti-Cyclic Citrullinated
Protein antibodies and Rheumatoid Factor were all nega-
tive. The levels of immunoglobulins were normal and
specific IgG for Aspergillus fumigatus, Alternaria alter-
nata and Micropolyspora faeni were all negative.
Echocardiography showed normal function of the left
ventricle with no signs of pulmonary hypertension. There
was minimal pericardial effusion and no hemodynamic
repercussion.
Broad-spectrum antibiotics were given for 14 days in case
of eventual (atypical) infection. His clinical situation did not
improve so a bronchoscopy was performed with bronchoal-
veolar lavage. This showed bilateral inflamed mucosa. A
PCR was negative for Mycoplasma and Chlamydia. TheFigure 1 Chest X-ray at time of first admission shows diffuse
diffuse reticulonodular pattern.cultures and the Ziehl-Nielsen staining were negative. PCR
of the urine was negative for Legionella. Treatment was
subsequently altered to high dose corticosteroids because of
the suspicion of an interstitial lung disease.
As the patient developed progressive shortness of
breath and became oxygen dependent, even under ther-
apy with corticosteroids, the patient was referred to our
university hospital for a second opinion. He had lost six
pounds since the start of his complaints. Examination of
the patient’s abdomen and heart sounds were unremark-
able. We heard ronchi in the base of both lungs. There
were clinically no enlarged lymph nodes, skin changes
or peripheral edema.
Biochemically there was leucocytosis (17,3 x10-9/L com-
pared to the normal limit: 4,3-10,0 x10-9/L) and C-reactive
protein levels of 10,5 mg/L (normal <5 mg/L) (Table 1).
The arterial pO2 was decreased to 76 mmHg with a
pCO2 of 37,5 mmHg and a pH of 7,45. The ground-
glass opacities and thickening of interlobular septa at
repeat CT-scan (Figure 2B) were clearly increased
compared with the scan six weeks earlier. A spirom-
etry showed a mixed obstructive restrictive pattern.
Central biopsies were taken with bronchoscopy. Anato-
mopathological examination revealed the presence of
metastatic carcinoma, probably stomach, pancreas or
bile duct in origin.
An additional gastroscopy was performed. This showed
an image of an extended complicated ulceration of the an-
trum, suspicious for malignancy. Anatomopathological
evaluation of the biopsies of the ulceration at gastroscopy
showed a primary adenocarcinoma of the stomach, with
focal signet ring differentiation.
A whole body diffusion-weighted Magnetic Resonance
Imaging (MRI) examination (WB-DWI) confirmed the
presence of a large tumour at the lesser curvature of the
stomach (Figure 3A, B; arrow) with diffuse lung, pleural
and mediastinal metastases as well as skeletal metastases
in a right-sided rib and right iliac wing, depicted as
clearly hyperintense lesions on DWI-images (Figure 3C,
D) . Biochemically the patient had a Carcino-embryonal
antigen of 7,3 mg/L (normally <3,8 mg/L).
After establishing this final diagnosis, biweekly chemo-
therapy was started with cisplatinum plus 5-Fluoro-Uracil;
this was well tolerated by the patient. Immediately after
the start of the chemotherapy the patients’ dyspnea
improved and he did not need oxygen administration.
A radiologic evaluation after 2 months of treatment
revealed partial remission according to RECIST criteria,
with resolution of clinical symptoms. There was clear,
be it partial, regression of the primary tumour, lung,
pleural, mediastinal and skeletal metastases, depicted
by a clear loss of hyperintensity on DWI-images
(Figure 4, arrows indicate site of gastric cancer and
skeletal metastases).
Figure 2 (A) High resolution computed tomography of the chest at time of first admission shows bilateral areas of ground-glass
opacification and diffusely thickened interlobular septa. Moreover it showed the presence of hilar and mediastinal adenopathies. (B) Repeat
scan after broad-spectrum antibiotics and high-dose corticosteroids shows progression of the interstitial disease.
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The most common primary tumours associated with pul-
monary lymphangitic carcinomatosis are breast, stomach,
pancreas, lung, and prostate cancer (Table 2) [1].
This has been confirmed in a retrospective study with
43 patients with lymphangitic carcinomatosis: 23
patients had primary lung cancer, 9 breast cancer, 8 with
large intestinal carcinoma and 6 gastric carcinoma [3].
However, virtually any metastatic neoplasm can cause
pulmonary lymphangitic carcinomatosis, for example
there are case reports where the primary tumours were
of cutaneous angiosarcoma or lip cancer [4,5]. In
patients with gastric cancer the lymphatic spread is most
commonly directed through the diaphragm and pleural
surfaces, or directed in a retrograde way through the
lymphatics from hilar lymph node metastases [6].
Gastric cancer is one of the most common cancers
worldwide, accounting for about eight percent of new
cancers [7]. Although the worldwide incidence hasTable 1 Blood results at first admission and in our hospital
Test First admission
Hemoglobin (g/dl) 15.3
White-cell count (x10^9/l) 8.9
Neutrophils (%) 69.6
Lymphocytes (%) 22.7
Platelet count (x10^9/l) 330
Creatinin (mg/dl) 0.75
Ureum (mg/dl) 37
C-reactive protein (mg/l) 3.8
Prothrombin time (ratio) 1.05
Aspartate aminotransferase (U/l) 35
Alanine aminotransferase (U/l) 43
Gamma-GT (U/l) 41
Alkaline phosphate (U/l) 253
Lactate dehydrogenase (U/l) 356declined rapidly over the recent few decades, the abso-
lute number of new cases per year is increasing again,
mainly due to aging of the world’s population. Further-
more, for reasons that are unclear, the trend towards de-
clining incidence in young patients has been interrupted
and replaced by an upward trend in recent years [8].
There are two distinct pathological types of gastric
adenocarcinoma: intestinal (well-differentiated) and dif-
fuse (undifferentiated), each with distinct morphologic
appearances, pathogenesis, and genetic profiles [9]. The
morphological differences are attributable to intercellular
adhesion molecules, which are well preserved in
intestinal-type tumours and defective in diffuse carcin-
omas [10]. The main carcinogenic event in diffuse
adenocarcinoma of the stomach is loss of expression of E-
cadherin, a key cell surface protein for establishing inter-
cellular connections. Clinically, diffuse adenocarcinomas
can give rise to infiltration of the gastric wall (i.e., linitis















Figure 3 (A,B) WB-DWI with b1000-images and T2-weighted images in the coronal plane shows a tumoral mass in the lesser curvature
of the stomach (arrow), (C,D) with diffuse metastases in the lungs and mediastinum as well as skeletal metastases in a right-sided rib
and right iliac wing (arrows).
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prognosis [11]. Signet ring histology is an independent
predictor of poor prognosis in gastric adenocarcinoma
[12]. The prognosis of an adenocarcinoma of the stomach
is highly dependent on the stage in which the tumour is
detected [13]. Accurate staging is pivotal prior in selecting
appropriate therapy. MRI is emerging as an efficient
whole-body imaging modality combining anatomical andFigure 4 (A,B) WB-DWI with b1000-images and T2-weighted images i
tumour (arrow), (C,D) diffuse metastases in the lungs and mediastinu
(arrows).functional sequences in clinically efficient scanning times
with adequate spatial resolution. Several studies have indi-
cated the additional value of WB-DWI to anatomical im-
aging for tumour detection, staging and (early) treatment
assessment in various solid tumours [14]. WB-DWI
depicts tumoral lesions by measuring water diffusion dif-
ferences, which correlate with cellular density. Tumours
are depicted with high signal compared to the backgroundn the coronal plane shows clear partial regression of the gastric
m and skeletal metastases in a right-sided rib and right iliac wing
Table 2 common locations of primary tumours associated
with pulmonary lymphangitic carcinomatosis (1)
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better detection of primary tumours of the gastro-
intestinal tract and metastases compared to CT. In par-
ticular gastric tumours, liver metastases, lymph adenopa-
thies, peritoneal and skeletal metastases can be detected
with high accuracy [15-17].
Based on these properties and the known variable ac-
curacy of fluorodeoxyglucose (FDG) positron emission
tomography in staging gastric cancer, we opted for WB-
DWI for staging and follow-up in this specific setting.
Additionally, WB-DWI obviates the need for contrast-
agent injection, making it useful in patients with
impaired renal function or known contrast-allergy.
Patients with primary gastric cancer and lymphangitic
carcinomatosis usually present with progressive short-
ness of breath lasting for two to four months before def-
inite diagnosis [6]. Often these patients experience no
gastric complaints at all. In a series of six young patientsTable 3 Radiologic characteristics of pulmonary
lymphangitic carcinomatosis (6)
Chest radiography
- Coarse bronchovascular markings with irregular outline
- Coarse reticulonodular pattern with intraparenchymal extension of
tumour
- Unilateral or bilateral changes predominantly in the lower lobes of
the lungs
- Kerley A and B lines
- Hilar and mediastinal lymphadenopathy (20-40% of cases); usually
asymmetric
- Pleural effusion (30-50% of cases)
- No abnormalities (30-50% of cases)
Chest CT scan
- Smooth (early stage) and nodular (late stage) thickening of
interlobular septa and peribronchovascular interstitium
- Polygonal arcades with thickened limbs from thickened septa of
adjacent lobules
- Normal lung architecture is maintained
- Ground-glass appearance from interstitial edema or extension of the
tumour into the parenchyma(aged from 21–29 years) only one had gastrointestinal
symptoms (nausea and epigastric burning) [18]. A study
of pulmonary function in patients with lymphangitic car-
cinomatosis showed a restrictive ventilatory function de-
fect, a reduction in the diffusing capacity, reduced
compliance and hypoxemia without hypercapnia [19].
Our patient had an obstructive and restrictive lung pat-
tern, but his lung function was not well performed be-
cause of the pain.
Chest radiography and CT of gastric patients have vari-
ous and often nonspecific appearances or may be normal
(Table 3) [6]. Due to lack of specific radiological features,
the final diagnosis can often only be made by biopsy. In
the study of Dennstedt et al. the final diagnosis was only
made at autopsy in four of six patients with a primary gas-
tric tumour and lymphangitic carcinomatosis [18]. In gen-
eral, diagnosis may be delayed due to the combination of
aspecific symptoms, uncertain initial diagnostic work-up
and a low index of suspicion for malignancy.
The general prognosis of patients with lymphangitis
carcinomatosis is poor with an average survival of only
three months in historical series [1]. Patients included in
the study of Dennstedt et al. (six patients with an aver-
age age of 26 years and a primary gastric tumour) had a
mean survival time of only 22 days after their first ad-
mission to hospital [14]. Anatomopathological examin-
ation revealed an adenocarcinoma of the diffuse type in
all of the patients [18]. Moreover, both the patient in the
study of Desigan [6] and our patient had an adenocar-
cinoma with focal signet cell carcinoma, which is asso-
ciated with a worse prognosis [12,20], although there are
publications that didn’t show a prognostic effect [21].
We might therefore conclude that an adenocarcinoma
of the diffuse type might be a predictor for lymphangitic
carcinomatosis. The number of patients is too small to
make definitive conclusions.Conclusion
It is important to consider the possibility of lymphangitic
carcinomatosis in patients with: progressive dyspnoea;
no other known causes of interstitial lung disease; or an
interstitial pattern demonstrated on CT or chest radio-
graphs. When there is doubt about the exact diagnosis, a
biopsy must be performed in order not to lose time for
starting the necessary treatment, even in young patients
where a malignancy is not expected.Consent
Written informed consent for publication of the clinical
details and clinical images was obtained from the patient.
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